Altiratinib (DCC2701)
目录号: A14387
c-Met/VEGFR 抑制剂
Altiratinib 是一种新型的 c-MET/TIE-2/VEGFR 抑制剂;在体内有效减少肿瘤负担,并且与体外的 HGF 拮抗剂相比,可以阻断 c-MET pTyr(1349)-介导的信号传导、细胞生长和迁移。
Discription | Altiratinib is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro. | ||
---|---|---|---|
Targets |
|
目录号 | A14387 |
---|---|
分子式 | C26H21F3N4O4 |
分子量 | 510.46 |
CAS号 | 1345847-93-9 |
SMILES | FC1=CC=C(NC(C2(C(NC3=C(F)C=C(OC4=CC(/N=C(O)/C5CC5)=NC=C4)C(F)=C3)=O)CC2)=O)C=C1 |
其他名称 | DCC-2701, DCC2701, DCC 2701, DP 5164, DP5164, DP-5164 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 99 mg/mL (193.94 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 19.59 mL | 97.95 mL | 195.9 mL |
0.5 mM | 3.92 mL | 19.59 mL | 39.18 mL |
1 mM | 1.96 mL | 9.8 mL | 19.59 mL |
5 mM | 0.39 mL | 1.96 mL | 3.92 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2